GI262570, a tyrosine-based PPARγ agonist, reduces...

GI262570, a tyrosine-based PPARγ agonist, reduces triglycerides and increases HDL-C concentrations in patients with type 2 diabetes mellitus when combined with glibenclamide treatment

Lata Kler, Robert C. Edwards, Simon J. McNeil, Patrick Round
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Year:
2000
Language:
english
DOI:
10.1016/s0168-8227(00)81593-4
File:
PDF, 207 KB
english, 2000
Conversion to is in progress
Conversion to is failed